Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.
Lorusso V, Crucitta E, Silvestris N, Catino A, Caporusso L, Mazzei A, Guida M, Latorre A, Sambiasi D, D'Amico C, Schittulli F, Calabrese P, De Lena M.
Lorusso V, et al. Among authors: d amico c, sambiasi d.
Br J Cancer. 2003 Feb 24;88(4):491-5. doi: 10.1038/sj.bjc.6600780.
Br J Cancer. 2003.
PMID: 12592360
Free PMC article.
Clinical Trial.